AI reveals true age of your organs
AI technology now predicts your organs' biological age from tissue samples, offering early disease detection without invasive biopsies.
New Hope for Babies with HIV
New research brings hope for babies with HIV using triple therapy to clear the virus from their bodies permanently.
Study Shows Ferroptosis Vulnerability in AML
New study reveals ferroptosis vulnerability in AML cells. Learn how this iron-dependent cell death mechanism offers new hope for treating…
GLP-1 Drug May Cut MACE Risk in High-Risk Patients
New research finds GLP-1 drug tirzepatide cuts MACE risk in high-risk patients with type 2 diabetes and cardiovascular disease.
Study Explores Blood Therapy Against Forever Chemicals
Blood therapy shows promise in cutting PFAS and microplastic levels, with a new study revealing double filtration apheresis reduces harmful…
Arginine helps T cells detect tumors and viruses
New research shows how arginine t cells detect tumors and viruses by regulating protein machinery for effective immune system responses.
Beaubrun and Acharya demand diagnostics before antibiotics
Rapid molecular diagnostics could slash hospital infection detection times, experts say, as the TRACE‑CPE project compares fast PCR tests with…
ProMIS Alzheimer’s Antibody Shows Promising Early Results
Early Phase Ib results show ProMIS Alzheimer's antibody PMN310 safely targets amyloid‑beta oligomers with low ARIA rates, offering hope for…
Billion-dollar barrier blocking access to Ozempic and Wegovy
Ozempic and Wegovy may be cost-effective, but insurance barriers block access. Learn why GLP-1 medications are restricted and the impact…
Popular drug linked to slower aging
GLP-1 drugs like Ozempic may slow aging by improving DNA markers, new research reveals. Discover how these medications impact longevity.